Indian Pharmaceuticals & Biotech Upcoming Dividends

Abbott India

Market Cap: ₹554.1b

Operates as a pharmaceutical company in India.

Mercury Laboratories

Market Cap: ₹910.6m

Engages in manufacturing, selling, exporting, and dealing in various pharmaceutical drugs and medicines for mother and child healthcare in India and internationally.

Procter & Gamble Health

Market Cap: ₹102.7b

Manufactures and markets pharmaceuticals and chemical products in India and internationally.

Dr. Reddy's Laboratories

Market Cap: ₹1.1t

Operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.

Caplin Point Laboratories

Market Cap: ₹177.2b

Engages in the development, production, marketing, and export of generic formulations and branded products in India.

Pfizer

Market Cap: ₹209.2b

Engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally.

Jenburkt Pharmaceuticals

Market Cap: ₹5.1b

Researches and develops, manufactures, and markets pharmaceutical and healthcare products in India.

Panchsheel Organics

Market Cap: ₹1.6b

Engages in the manufacture and trading of bulk drugs and intermediates in India and internationally.

Alkem Laboratories

Market Cap: ₹633.9b

A pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.

Jubilant Pharmova

Market Cap: ₹149.8b

Operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally.

Cipla

Market Cap: ₹1.1t

Manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.

Divi's Laboratories

Market Cap: ₹1.8t

Engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.

Granules India

Market Cap: ₹189.1b

Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally.

Vimta Labs

Market Cap: ₹23.3b

Provides contract research and testing services in India and internationally.

Anuh Pharma

Market Cap: ₹7.6b

Engages in the manufacture and sale of bulk drugs and chemicals in India.

J. B. Chemicals & Pharmaceuticals

Market Cap: ₹361.6b

Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.

Fermenta Biotech

Market Cap: ₹9.7b

Manufactures and markets chemicals, bulk drugs, and enzymes in India, Europe, the United States, and internationally.

Ipca Laboratories

Market Cap: ₹409.4b

An integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia.

Concord Biotech

Market Cap: ₹140.5b

A biopharma company, engages in the research and development, manufacture, market, and sale of pharmaceutical products in India and internationally.

Eris Lifesciences

Market Cap: ₹189.2b

Provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally.

Venus Remedies

Market Cap: ₹22.9b

Engages in the pharmaceutical business in India and internationally.

TTK Healthcare

Market Cap: ₹12.5b

Engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India.

Sanofi Consumer Healthcare India

Market Cap: ₹106.0b

Operates as a fast-moving consumer healthcare company in India.

Smruthi Organics

Market Cap: ₹1.4b

Manufactures and markets active pharmaceutical ingredient (API) products to India.

Syngene International

Market Cap: ₹178.3b

A contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally.

Gland Pharma

Market Cap: ₹380.0b

Engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally.

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹356.2b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.